MetLife (NYSE:MET) Issues Quarterly Earnings Results

MetLife (NYSE:METGet Free Report) announced its quarterly earnings data on Wednesday. The financial services provider reported $2.43 EPS for the quarter, beating analysts’ consensus estimates of $2.30 by $0.13, Zacks reports. The firm had revenue of $19.07 billion during the quarter, compared to analysts’ expectations of $19.67 billion. MetLife had a return on equity of 22.60% and a net margin of 4.66%.The company’s revenue for the quarter was up 10.5% compared to the same quarter last year. During the same quarter last year, the firm posted $2.02 earnings per share.

MetLife Stock Up 0.3%

NYSE:MET traded up $0.32 on Wednesday, hitting $96.45. The stock had a trading volume of 4,686,212 shares, compared to its average volume of 3,968,851. MetLife has a 1 year low of $67.33 and a 1 year high of $97.80. The firm’s fifty day simple moving average is $89.44 and its two-hundred day simple moving average is $80.54. The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.20 and a current ratio of 0.20. The stock has a market cap of $62.06 billion, a P/E ratio of 18.69, a price-to-earnings-growth ratio of 0.74 and a beta of 0.78.

MetLife Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 8th. Shareholders of record on Tuesday, August 4th will be given a $0.5925 dividend. This represents a $2.37 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend is Tuesday, August 4th. MetLife’s dividend payout ratio is presently 45.93%.

MetLife announced that its board has approved a stock buyback plan on Wednesday, August 5th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the financial services provider to reacquire up to 4.8% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s board believes its stock is undervalued.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the business. CreativeOne Wealth LLC grew its stake in MetLife by 1.3% in the 4th quarter. CreativeOne Wealth LLC now owns 10,156 shares of the financial services provider’s stock valued at $802,000 after purchasing an additional 135 shares during the period. Triumph Capital Management raised its stake in shares of MetLife by 4.0% during the 4th quarter. Triumph Capital Management now owns 3,712 shares of the financial services provider’s stock worth $293,000 after purchasing an additional 142 shares during the period. Clark Capital Management Group Inc. raised its stake in shares of MetLife by 4.8% during the 3rd quarter. Clark Capital Management Group Inc. now owns 3,175 shares of the financial services provider’s stock worth $262,000 after purchasing an additional 145 shares during the period. Wilmington Savings Fund Society FSB boosted its holdings in shares of MetLife by 3.6% in the 4th quarter. Wilmington Savings Fund Society FSB now owns 4,349 shares of the financial services provider’s stock worth $343,000 after buying an additional 151 shares during the last quarter. Finally, IHT Wealth Management LLC grew its position in MetLife by 2.0% during the fourth quarter. IHT Wealth Management LLC now owns 7,946 shares of the financial services provider’s stock valued at $627,000 after buying an additional 154 shares during the period. Hedge funds and other institutional investors own 94.99% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on MET shares. Bank of America lowered their target price on MetLife from $103.00 to $99.00 and set a “buy” rating on the stock in a research report on Tuesday, April 14th. TD Cowen boosted their price target on shares of MetLife from $87.00 to $105.00 and gave the company a “buy” rating in a research note on Wednesday, July 22nd. Mizuho upped their price objective on shares of MetLife from $95.00 to $102.00 and gave the stock an “outperform” rating in a report on Thursday, July 9th. Wells Fargo & Company raised their price objective on shares of MetLife from $95.00 to $101.00 and gave the company an “overweight” rating in a research note on Thursday, July 9th. Finally, Atlantic Securities set a $103.00 price objective on shares of MetLife in a report on Wednesday, July 15th. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $100.50.

Get Our Latest Analysis on MET

MetLife News Roundup

Here are the key news stories impacting MetLife this week:

  • Positive Sentiment: MetLife reported second-quarter 2026 earnings of $2.43 per share, exceeding the $2.30 analyst consensus and rising from $2.02 a year earlier. Profit benefited from favorable underwriting performance and volume growth, supporting investor confidence in the company’s operating momentum. MetLife’s Q2 earnings gain from favorable underwriting, volume growth
  • Positive Sentiment: The board approved a new $3 billion share-repurchase authorization, incremental to approximately $400 million remaining under the prior program. The authorization allows buybacks of up to roughly 4.8% of outstanding shares, potentially supporting per-share results and signaling management’s confidence in MetLife’s valuation and capital-generation ability. MetLife Announces New $3 Billion Share Repurchase Authorization
  • Positive Sentiment: Revenue increased 10.5% year over year, while MetLife generated a 22.6% return on equity, reinforcing the case that growth and profitability remain strong despite the revenue shortfall versus estimates. Compared to Estimates, MetLife Q2 Earnings: A Look at Key Metrics
  • Neutral Sentiment: MetLife Investment Management closed a private-equity fund with approximately $1.2 billion in commitments. The transaction expands the asset-management platform, although its immediate effect on consolidated earnings and the stock is likely limited. MetLife Investment Management Closes $1.2 Billion Private Equity Partners Fund III
  • Negative Sentiment: Quarterly revenue of approximately $19.07 billion fell short of the $19.67 billion consensus estimate. The revenue miss is a modest counterweight to the stronger-than-expected EPS result and could limit further upside if investors focus on top-line execution. MetLife quarterly earnings report

MetLife Company Profile

(Get Free Report)

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.

Featured Stories

Earnings History for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.